NewsNovo
StockStory analysts recommend avoiding Bath and Body Works shares, citing a three-year trend of shrinking demand and a revenue outlook that suggests new products will not soon reverse the company's top-line decline.
The investment firm argues that despite the stock's recent price drop, the risk-reward profile does not justify ownership at this time.
Over the past six months, Bath and Body Works shares have fallen to $16.35, resulting in a 12% loss. This performance contrasts sharply with the 16.3% gain recorded by the S&P 500 over the same period.
The firm notes that while the stock has become cheaper, it does not currently present a compelling buying opportunity. A primary concern for the analysts is the company's organic growth trajectory.
Keep reading